Skip to main content
Fig. 3 | BMC Ophthalmology

Fig. 3

From: The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study

Fig. 3

Graph showing variations in MGL following PC-PGA, PF-PGA, and PC-PGA + DQS treatment. *P < 0.001, repeated measures ANOVA with post hoc Bonferroni correction. ANOVA = analysis of variance; DQS = diquafosol; MGL = meibomian gland loss; PC-PGA = preservative-containing prostaglandin analogs; PC-PGA + DQS = preservative-containing prostaglandin analogs and diquafosol; PF-PGA = preservative-free prostaglandin analogs

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us